Download
https://www.ndtvprofit.com/research-reports/pharma-q2-preview-domestic-growth-currency-to-propel-revenues-margins-ticking-up-sequentially-icici-direct?utm_source=telegram&utm_medium=referral&utm_campaign=socialshare
India's pharma industry likely had a decent Q2 amid strong growth in domestic formulations and a stable portfolio stateside.
Share